Monthly Archives: August 2020

A2Z Smart Technologies Provides Update On Lead Project

Preventing serious harm to car passengers and fatalities: A2Z's Fuel Tank Inertia Capsule System intends to dramatically reduce the risk of automobile fuel tank combustion in the event of collision

Over 181,500 highway vehicle fires reported annually in the United States alone, representing an estimated – $1.1 billion in property loss

TEL AVIV, ISRAEL / ACCESSWIRE / August 17, 2020 / A2Z Smart Technologies Corp. ("A2Z" or the "Company") (TSXV:AZ) (OTCPK:AAZZF) (FSE:A23), an innovative technology company specializing in state-of-the-art automation and electronics technology, today announces plans to roll out its Fuel Tank Inertia Capsule System – or FTICS – in Q4 of this year. A2Z's strategy is to enter into a pilot installation of the FTICS with the Israeli Military. The FTICS is a system that deploys in the event of a vehicle collision and is designed to eliminate the risk of the fuel tank combusting and causing fatal harm to passengers and property loss. Each year in the United States alone, over 181,500 highway vehicle fires are caused by fuel tank combustion.

For over 30 years, A2Z has been engineering, producing and maintaining complex military-grade electronic systems and unmanned robotic platforms that have been used by military forces and government agencies to combat terrorism, handle bomb disposals and deal with emergencies.

FTICS is a unique cutting-edge lifesaving technology that is located within the fuel tank of a car. Upon collision, FTICS releases a proprietary substance into the gas tank, solidifying the fuel and eliminating the possibility of combustion and thereby preventing fires. The fuel tank is also lined with a special coating to ensure the fuel does not leak. This eliminates vehicle fires, saving lives and preventing serious harm to passengers, as well as saving billions in property damage. To see how it works in detail, click here.

A2Z plans to cooperate with the Israeli Defense Force and commence a pilot program in Q4 2020. As 2021 approaches and based on the results of the pilot, A2Z intends to initiate trials with car manufacturers. The vision of A2Z is for FTICS to be integrated at the manufacturing level globally, and the Company will adopt a two-pronged approach: (i) retrofitting vehicles, and (ii) maintaining full cooperation with car manufacturers to embed FTICS on the production line as mandatory.

"This is a significant step forward for A2Z Technologies" said Bentsur Joseph, CEO, A2Z Smart Technologies Corp., and continued, "We firmly believe FTICS will revolutionize the automotive industry and be a game-changer in terms of passenger safety and damage limitation as a result of collisions. We are the first company to offer fire protection from tank combustion and this – truly is the future. For A2Z Technologies, this is fundamentally about saving people's lives across the globe."

For more information about A2Z Technologies, visit www.a2zas.com.

ENDS

Notes for Editors:

*https://www.statista.com/statistics/377006/nmber-of-us-highway-vehicle-fires/

**https://www.usfa.fema.gov/downloads/pdf/statistics/v19i2.pdf

According to **FEMA data, between 2014-2016 83% of highway vehicle fires occurred in passenger vehicles.

About A2Z Smart Technologies Corp.:

A2Z Smart Technologies Corp. is considered to be one of the top innovative technology companies in Israel- providing products to the Israeli Defense and Security Forces-specializing in military unmanned robotics and state-of-the-art automation and electronics technology.

For over 30 years A2Z has been working closely and collaborating with the Israeli government (e.g., Israel Defense Forces, Israel Police, Ministry of Defense, etc.) in order to engineer, produce and maintain complex electronic systems, and unmanned robotic platforms. A2Z is a financially sound company with stable cash flow, owed to its long-term contracts with governmental agencies and various large corporations.

By employing our knowledge of technology innovation and business strategy we intend to expand our reach into civilian markets and to create durable, lifesaving everyday products with the highest military engineering grade.

SOURCE: A2Z Smart Technologies Corp.

ReleaseID: 601753

Helix Technologies Q2 2020 Results: Record Revenues, Positive Cash Flows From Operations, and Positive EBITDA

Helix Technologies Q2 2020 Results: Record Revenues, Positive Cash Flows From Operations, and Positive EBITDA

DENVER, CO / ACCESSWIRE / August 17, 2020 / Helix Technologies, Inc, (OTCQB:HLIX) (the "Company") today reported its results for the second quarter of 2020, realizing its goal of achieving positive EBITDA and generating positive cash flow from operations, even in the face of the Covid-19 pandemic. The Company will be hosting an earnings call this afternoon at 4:30pm eastern time. Call info can be found at the bottom of this release.

"Those who have been following Helix Technologies know that we have always focused on the disciplined execution of our strategic plans, without fanfare or hype. We continue to deliver value to our expanding client base as their critical infrastructure partner, even as we continue to grow our organic market share and roll out new products in response to customer needs" said Helix Technologies CEO and Executive Chairman Zachary L. Venegas. "In a business and capital market environment that has at times ignored our constantly improving metrics and growing market share, we have stayed the course and achieved all of our 2020 financial goals already–setting the stage for an outstanding and exciting rest of the year. I can assure you that we are only getting started."

Highlights of Q2 and H1 2020 Include:

Grew first half revenue to $9.3mm, a 28% increase over H1 2019

Improved first half gross profit 39% to $4.7mm

Increased Software Gross Profit to $3.9mm in the first half, a 38% increase from 2019

Generated Software Adjusted EBITDA1 of $1.6mm in H1 2020, a 29% margin

Overall Adjusted EBITDA for H1 improved over $2mm from 2019 to $259k

Software revenue increased 20% from H1 2019 to $5.4mm, despite the Coronavirus outbreak and associated market headwinds

Improved quarterly Software Gross Margin to 74%, a 17% improvement from Q2 2019

Posted Q2 Cash Flows from Operations of $446k, a 162% improvement from Q2 2019

$2mm in cash at the end of Q2, a 300% increase from Q4 2019

Launched Cannalytics Cultivation Platform, the first of its kind in the industry

Exceeded 200 Cannalytics clients, more than doubling users in just one quarter

Continued to expand the Helix ecosystem by adding new integration partners

The second quarter of 2020 was a landmark for Helix Technologies, reaching the critically important milestone of positive cash flow from operations, further distinguishing us from the rest of the industry. While companies across all sectors and industries were reeling from the Covid-19 pandemic, Helix's focus on operations, innovation, and strategic execution allowed us to post positive operating results."

Conference Call Info:

We recommend calling in approximately 10 minutes prior to the start of the call. There will be live Q&A on the call; questions can also be submitted ahead of time or during the call to ir@helixtechnologies.com.

Interested parties can participate in the call using the following information:

Time: Monday, August 17 2020, 4:30 p.m. EDT

Attendee Dial In: 785-424-1673 or 888-632-3385

Passcode or ID: 33895

If you can't make the live call, a recording will be available here

Sign up for Helix Technologies Investor Updates here.

Notes:

1We define Adjusted EBITDA as net loss before income tax expense, other income (loss), interest expense, depreciation and amortization expense, share based compensation expense, other operating gains and losses (such as impairment charges related to fixed and intangible assets and gains or losses on the sale of long-lived assets), if any, and other gains and losses associated with the mark to market of our convertible notes, contingent liabilities and warrant liabilities. From time to time, we may exclude from Adjusted EBITDA the impact of certain events, gains, losses or other charges that affect the period-to-period comparability of our operating performance. This measure should not be considered a substitute for operating loss, net loss, or net cash provided by operating activities that we have reported in accordance with GAAP.

Forward-Looking Statements

Except for historical information, all of the statements, expectations, and assumptions contained in this press release are forward-looking statements. Actual results might differ materially from those explicit or implicit in the forward-looking statements. Important factors that could cause actual results to differ materially include: our ability to fund our operations and pay any outstanding debt; fluctuations in our financial results; general economic risks; the volatile nature of the market for our products and services and other factors that could impact our anticipated growth; our ability to manage our growth; changes in laws and regulations regarding the cannabis industry and service providers in the cannabis industry; reliance on key personnel; our ability to compete effectively; security and other risks associated with our business; intellectual property risks; and other risk factors set forth from time to time in our SEC filings. Helix Technologies assumes no obligation and does not intend to update these forward-looking statements, except as required by law.

About Helix Technologies, Inc.

Helix Technologies, Inc. (OTCQB: HLIX) is the leading provider of critical infrastructure services, helping owners and operators of licensed cannabis businesses stay competitive and compliant while mitigating risk. Through its proprietary technology suite and security services, Helix Technologies provides comprehensive supply chain management, compliance tools, and asset protection for any license type in any regulated cannabis market. While Helix provides services to the Cannabis and Hemp Industries, the Company does not deal directly with the plant or any derivative products. Helix Technologies' products reach over 2,000 customer locations in 36 states and 9 countries and has processed over $20 billion in cannabis sales. For more information on Helix Technologies and to sign up for investor updates, visit us at www.helixtechnologies.com. and follow us on Facebook, Twitter and LinkedIn. Sign up for the CannaPulse Newsletter for legislative changes, software updates and more.

Media Contact:
Colt Peterson
Helix Technologies, Inc.
303-324-1022
press@helixtechnologies.com

IR Contact:
Scott Ogur, CFA
Helix Technologies, Inc.
ir@helixtechnologies.com

SOURCE: Helix Technologies, Inc.

ReleaseID: 601957

Vanadium One Closes First Tranche of Non-Brokered Private Placement of Common Share Units and Flow Through Share Units

Proceeds to be used to drill 3,500 meters to expand resources at its Mont Sorcier project in Quebec
RAB Capital to become a reporting insider of the Company

TORONTO, ON / ACCESSWIRE / August 17,2020 / Vanadium One Iron Corp. ("Vanadium One" or the "Company") (TSXV:VONE), ) is pleased to announce that it has closed the first tranche of the hard dollar unit segment of the previously announced non-brokered private placement (the "Offering") of common share units (the "Units")in the amount of C$459,000 subject to final approval from the TSX Venture Exchange (‘TSXV'). In addition, the Company is pleased to announced it has commitments for 6,000,000 Units of its offering of Flow Through Share Units for anticipated gross proceeds of C$1,080,000, which is planned to close on or around August 21, 2020 in conjunction with the Flow Through segment of the Offering.

In connection with the closing of the first tranche of the Offering the Company has issued 4,590,000 Units at a price of $0.10 per Unit for gross proceeds of C$459,000. Each Unit consists of one common share of the Company ("Share") plus one common share purchase warrant of the Company. Each Warrant shall entitle the holder to purchase one Share at a price of $0.15 for a period of 2 years following the Closing Date of the Offering.

Upon closing of the second tranche of the private placement, Vanadium One Iron is pleased to announce that RAB Capital will become a reporting insider of the Company and hold approximately 11 % of the basic shares outstanding. Philip Richards, Founder and President of RAB Capital stated "RAB Capital is investing because it believes Vanadium One's Mont Sorcier project is a world class asset and will generate strong strategic interest following the resource expansion expected from the current drill program. In addition to its premium product offering, the project is ideally situated with all major infrastructure in place and located in a world class mining and operating jurisdiction that will encourage future development."

Mark Brennan, Executive Chairman commented, "We are extremely delighted to have Philip and RAB Capital join Vanadium One Iron as a significant shareholder to support our efforts to make the Mont Sorcier project a reality. We view RAB Capital's strong support as highlighting the significant value potential we aim to unlock at Mont Sorcier."

The securities issued pursuant to the Offering will be subject to a four (4) month plus one (1) day statutory hold period. No finders fee was paid in connection with the Offering.

Approximately 39% of the total Offering under the Hard Dollar segment was taken up by Directors and Officers of the Company. As certain insiders of Vanadium One participated in the Offering, it is deemed to be a "related party transaction" as defined under Multilateral Instrument 61-101-Protection of Minority Security Holders in Special Transactions ("MI 61-101"). The Company is exempt from the formal valuation requirement of Section 5.4 of MI 61-101 pursuant to Subsection 5.5(b) of MI 61-101 and exempt from the minority approval requirements of Section 5.6 of MI 61-101 pursuant to Subsection 5.7(a) of MI 61-101.

The Company intends to use the gross proceeds of the Offering to fund costs to continue exploration and further definition of the Company's Mont Sorcier Iron and Vanadium Property and for general administration purposes.

Project Update

With robust iron ore market conditions continuing as global economies begin to lift recent restrictions related to COVID 19, Vanadium One is excited to get back into the field and continue to enhance the robust results published for the Mont Sorcier Project through its Preliminary Economic Assessment ("PEA") released early this year (February 27, 2020). The Company notes current 65% grade iron concentrates are trading at over US$125/t, well in excess of the US$92/t assumption that underpins the PEA. Going forward Vanadium One anticipates strong demand to continue as governments look to increase infrastructure funding to increase employment.

With funds in place, the Company plans to undertake a drill program of approximately 3,500 metres focusing on expanding the current resource at Mont Sorcier and deliver a new Mineral Resource Estimate by year end. The aim of the drill program is to increase the current resources to between 900 million to 1.1 billion tonnes at grades of between 24-34% magnetite. This is similar to the grade profile of the current resource. Investors are cautioned that this resource target is conceptual in nature at this time and there has been insufficient exploration to define a new mineral resource. In addition, the company plans to continue its ongoing discussions with various potential strategic partners to move the project forward.

The drill results are expected to enhance the value presented in the PEA as outlined in the Technical Report entitled "NI 43-101 Technical Report – Preliminary Economic Assessment (PEA) of the Mont Sorcier Project, Province of Quebec, Canada". The report was completed by CSA Global Consultants Canada Ltd, an ERM Company (CSA Global) and has an effective date of February 27, 2020. The report was prepared in accordance with Canadian Securities Administrators' National Instrument 43-101 ("NI 43-101") Standards of Disclosure for Mineral Projects. A summary of the results is highlighted below:

PEA Summary Results

The PEA was prepared by CSA Global incorporating contributions from Vulcan Technologies for the Iron and Vanadium Market Pricing Study. The PEA is preliminary in nature, as it includes Inferred Mineral Resources that are considered too speculative geologically to have the economic considerations applied to them that would enable them to be categorized as Mineral Reserves, and there is no certainty that the preliminary economic assessment will be realized.

The Technical Report is available for review under the Company's profile on SEDAR and on the Company's website.

Technical Disclosure

The reader is advised that the PEA summarized in this press release is intended to provide only an initial, high-level review of the project potential and design options. The PEA mine plan and economic model include numerous assumptions and the use of Inferred Mineral Resources. Inferred Mineral Resources are considered to be too speculative to be used in an economic analysis except as allowed for by National Instrument 43-101 in PEA studies. There is no guarantee the project economics described herein will be achieved.

Qualified Persons Statements

The PEA and other scientific and technical information contained in this news release were prepared by CSA Global, in accordance with the Canadian regulatory requirements set out in National Instrument 43-101, Standards of Disclosure for Mineral Projects ("NI 43-101"), and has been reviewed and approved by, as it relates to geology, sampling, drilling, exploration, and QAQC : Dr. Luke Longridge, Ph.D., P.Geo, Senior Geologist (CSA Global); as it relates to mineral resources: Dr. Adrian Martinez Vargas, Ph.D., P.Geo, Senior Resource Geologist (CSA Global); as it relates to metallurgy, processing and related infrastructure: Georgi Doundarov, M.Sc., P. Eng., PMP, CCP, (Magemi Mining Inc.) and Associate Metallurgical Engineer (CSA Global); as it relates to mining, related infrastructure, and mining costs: Karol Bartsch, BSc Mining (Hons), MAusIMM, Principal Mining Engineer (CSA Global); and as it relates to financial modelling and economic analysis: Bruce Pilcher, B.E. (Mining), Eur Ing, CEng, FIMMM, FAusIMM CP, Principal Mining Engineer (CSA Global) and Alex Veresezan, M.Sc., P.Eng., Manager – Mining (Americas). Dr. Luke Longridge, Dr. Adrian Martinez Vargas, Georgi Doundarov, Karol Bartsch, Bruce Pilcher and Alex Veresezan are all independent Qualified Persons ("QP"), as defined under NI 43-101.

The technical information contained in this news release has been reviewed and approved by Pierre-Jean Lafleur, P.Eng. (OIQ), who is a Qualified Person with respect to the Company's Mont Sorcier Project as defined under National Instrument 43-101.

About Vanadium One Iron Corp.:

Vanadium One Iron Corp. is a mineral exploration company headquartered in Toronto, Canada. The Company is focused on advancing its Mont Sorcier, Vanadium-rich, Magnetite Iron Ore Project, in Chibougamau, Quebec.

NOT FOR DISTRUBITION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES

ON BEHALF OF THE BOARD OF DIRECTORS OF VANADIUM ONE IRON CORP.

Cliff Hale-Sanders, President & CEO
Tel: 416-819-8558
csanders@vanadiumone.com
www.vanadiumone.com

Cautionary Note Regarding Forward-Looking Statements:

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

This news release contains "forward-looking information" including statements with respect to the future exploration performance of the Company. This forward-looking information involves known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of the Company to be materially different from any future results, performance or achievements of the Company, expressed or implied by such forward-looking statements. These risks, as well as others, are disclosed within the Company's filing on SEDAR, which investors are encouraged to review prior to any transaction involving the securities of the Company. Forward-looking information contained herein is provided as of the date of this news release and the Company disclaims any obligation, other than as required by law, to update any forward-looking information for any reason. There can be no assurance that forward-looking information will prove to be accurate and the reader is cautioned not to place undue reliance on such forward-looking information.

SOURCE: Vanadium One Iron Corp.

ReleaseID: 601841

Gatling Commences Drilling at Larder Gold Project in Ontario

VANCOUVER, BC / ACCESSWIRE / August 17, 2020 / GATLING EXPLORATION INC. (TSXV:GTR)(OTCQX:GATGF) (the "Company" or "Gatling) is pleased to announce that it has commenced a 13,000 meter drill program at its Larder Gold project in Ontario's Abitibi greenstone belt. Drilling will initially focus on connecting the Fernland and Cheminis deposits in order to establish a continuous 4.5 kilometer mineralized trend. Upcoming phases will test the western extension of Fernland, as well as near surface mineralization at all three high-grade deposits (see news release dated July 23, 2020 for further details). Regional mapping and sampling at priority target areas is also now underway.

About Gatling Exploration

Gatling Exploration is a Canadian gold exploration company focused on advancing the Larder Gold Project, located in the prolific Abitibi greenstone belt in Northern Ontario. The Larder property hosts three high-grade gold deposits along the Cadillac-Larder Lake Break, 35 kilometers east of Kirkland Lake. The project is 100% controlled by Gatling and is comprised of patented and unpatented claims, leases and mining licenses of occupation within the McVittie and McGarry Townships. The 3,370 hectare project area is positioned 7 kilometers west of the Kerr Addison Mine, which produced 11 million ounces of gold. All parts of the Larder property are accessible by truck or all-terrain vehicles on non-serviced roads and trails.

Qualified Person

The technical content of this news release has been reviewed and approved by Nathan Tribble, P. Geo., VP Exploration of Gatling Exploration, and a Qualified Person pursuant to National Instrument 43-101.

ON BEHALF OF THE BOARD OF DIRECTORS,

Nav Dhaliwal, President and CEO

Gatling Exploration Inc.

For further information on Gatling, contact Investor Relations

Telephone: 1-888-316-1050
Email: ir@gatlingexploration.com

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Forward Looking Statements: Statements contained in this news release that are not historical facts are forward-looking statements, which are subject to a number of known and unknown risks, uncertainness and other factors that may cause the actual results to differ materially from those anticipated in our forward-looking statements. Although we believe that the expectations in our forward-looking statements are reasonable, actual results may vary, and we cannot guarantee future results, levels of activity, performance or achievements.

SOURCE: Gatling Exploration Inc.

ReleaseID: 601899

Gold Terra Commences Drilling Program Today on the High-Grade Crestaurum Deposit in Yellowknife, NWT

VANCOUVER, BC / ACCESSWIRE / August 17, 2020 / Gold Terra Resource Corp. (TSX-V:YGT) (Frankfurt:TX0) (OTC PINK:TRXXF) ("Gold Terra" or the "Company) is pleased to announce the commencement of a 10,000 metre drilling program testing high-grade gold targets at its wholly owned Yellowknife City Gold project ("YCG") in the Northwest Territories.

Highlights:

Mobilization to site completed with one diamond drill turning
Upcoming drill program targeting high-grade Crestaurum deposit
Additional drilling planned targeting the Campbell Shear regional structure
Commencing drilling with a strong cash position following an equity raise of $7.1 million
COVID-19 protocols in place for drilling program

David Suda, President and CEO, stated, "The company is well funded and we are very excited to start drilling on the Crestaurum high-grade gold deposit, which has considerable potential for expansion along strike and at depth. Following Crestaurum, our drilling activities will focus on testing multiple new high-grade targets along the prolific Campbell Shear structure."

This first phase of drilling, consisting of seven holes totaling 3,700 metres, will cover a strike length of approximately 1 kilometre to test the depth extension of the Crestaurum deposit to 400 metres below surface, approximately 200 metres below the current resource limit, and to test the Daigle fault offset which displaces the deposit to the south (Link to long section). Following the first phase of drilling, the Company is planning to test the Crestaurum deposit deeper between 400 and 600 metres (Refer to news release dated July 21, 2020).

Gold Terra has received a Mineral Incentive Program ("MIP") grant of $86,000 from the Government of the Northwest Territories for exploration work on its YCG project. The proposed work program totaling $240,000 will mainly include ground geophysical surveys (Induced Polarisation) to cover the extension of the Campbell Shear zone onto the North Belt of the YCG property, immediately north of the Giant mine.

The Company is also planning to drill a number of targets on the high-grade Campbell Shear structure, which extends on the Company's property both north and south of the former Con and Giant mines, which have produced over 14 million ounces of gold (Refer to news release dated June 2, 2020).

Following the completion of the Crestaurum drilling program, the Company plans to update its mineral resource estimate for the YCG project at year-end. Currently, the project hosts a NI 43-101 inferred mineral resource estimate of 735,000 ounces of gold (12.8 million tonnes averaging 1.79 g/t Au) based on a gold price of US$1,300 per ounce (Refer to news release dated November 4, 2019).

The technical information contained in this news release has been approved by Joseph Campbell who is a Qualified Person as defined in National Instrument 43-101, Standards of Disclosure for Mineral Projects.

About Gold Terra's Yellowknife City Gold Project

The YCG project encompasses 790 sq. km of contiguous land immediately north, south and east of the City of Yellowknife in the Northwest Territories. Through a series of acquisitions, Gold Terra controls one of the six major high-grade gold camps in Canada. Being within 10 kilometres of the City of Yellowknife, the YCG is close to vital infrastructure, including all-season roads, air transportation, service providers, hydro-electric power and skilled tradespeople.

The YCG lies on the prolific Yellowknife greenstone belt, covering nearly 70 kilometres of strike length along the main mineralized shear system that host the former-producing high-grade Con and Giant gold mines. The Company's exploration programs have successfully identified significant zones of gold mineralization and multiple targets that remain to be tested which reinforces the Company's objective of re-establishing Yellowknife as one of the premier gold mining districts in Canada.

Visit our website at www.goldterracorp.com.

For more information, please contact:

David Suda, President and CEO
Phone: 604-928-3101 | Toll-Free: 1-855-737-2684
dsuda@goldterracorp.com

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Cautionary Note Regarding Forward-Looking Information

Certain statements made and information contained in this news release constitute "forward-looking information" within the meaning of applicable securities legislation ("forward-looking information"). Generally, this forward-looking information can, but not always, be identified by use of forward-looking terminology such as "plans", "expects" or "does not expect", "is expected", "budget", "scheduled", "estimates", "forecasts", "intends", "anticipates" or "does not anticipate", or "believes", or variations of such words and phrases or statements that certain actions, events, conditions or results "will", "may", "could", "would", "might" or "will be taken", "occur" or "be achieved" or the negative connotations thereof.

All statements other than statements of historical fact may be forward-looking information. Forward-looking information is necessarily based on estimates and assumptions that are inherently subject to known and unknown risks, uncertainties and other factors that may cause the actual results, level of activity, performance or achievements of the Company to be materially different from those expressed or implied by such forward-looking information. In particular, this news release contains forward-looking information regarding the Crestaurum deposit having considerable potential for expansion along strike and at depth, planning to test the Crestaurum deposit deeper between 400 and 600 metres, and planning to drill a number of targets on the high-grade Campbell Shear structure, and the Company's objective of re-establishing Yellowknife as one of the premier gold mining districts in Canada.

There can be no assurance that such statements will prove to be accurate, as the Company's actual results and future events could differ materially from those anticipated in this forward-looking information as a result of the factors discussed in the "Risk Factors" section in the Company's most recent MD&A and annual information form available under the Company's profile at www.sedar.com.

Although the Company has attempted to identify important factors that would cause actual results to differ materially from those contained in forward-looking information, there may be other factors that cause results not to be as anticipated, estimated or intended. The forward-looking information contained in this news release is based on information available to the Company as of the date of this news release. There can be no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. All of the forward-looking information contained in this news release is qualified by these cautionary statements. Readers are cautioned not to place undue reliance on forward-looking information due to the inherent uncertainty thereof. Except as required under applicable securities legislation and regulations applicable to the Company, the Company does not intend, and does not assume any obligation, to update this forward-looking information.

SOURCE: Gold Terra Resource Corp

ReleaseID: 601945

Transportation and Logistics Systems, Inc. Announces Financial Results for the Three and Six Months Ended June 30, 2020

Turnaround Efforts Lead to Positive EBITDA at Operating Subsidiaries

JUPITER, FL / ACCESSWIRE / August 17, 2020 / Transportation and Logistics Systems, Inc. (OTC PINK:TLSS), ("TLSS", or the "Company"), a leading eCommerce fulfillment service provider, today announced that on August 14, 2020, the Company had timely filed its Quarterly Report on Form 10-Q, for the three and six months ended June 30, 2020.

John Mercadante, Chairman and CEO of TLSS, commented, "Due to the success of the restructuring efforts commenced in mid-March 2020, the Company also saw marked improvement in its overall operating performance, including generating for the first time, positive EBITDA from its operating subsidiaries of approximately $551,000 during the three months ended June 30, 2020. Shortly, we will be issuing a shareholder update detailing the specific restructuring measures implemented and the results achieved to date, as well as discussing the Company's go-forward plans."

Financial Results for the Three Months Ended June 30, 2020

Revenue for the three months ended June 30, 2020 increased $458,000, or 5.7%, to $8,559,000 as compared to $8,101,000 for same prior year period. Such increase was due primarily to: (i) the Company's expansion into new markets in Florida, Georgia, Ohio and Tennessee that were not operational during the first and second quarters of 2019; and (ii) securing Payroll Protection Program loans which provided the funds needed to enable the Company to maintain its level of employed drivers to meet the increased delivery demand of its primary customer during the height of the COVID-19 pandemic.

The Company had a loss from operations of $1,961,000 for the three months ended June 30, 2020, which is comprised of (i) income from operating subsidiaries of $551,000 and (ii) a loss from the parent company of $2,512,000, of which $1,999,749 is attributable to non-cash stock-based compensation and consulting fees, as compared to a loss from operations of $6,338,000 for the same prior year period.

The Company had a net loss of $67,655,000 for the six months ended June 30, 2020 due to: (i) the loss from operations of $1,961,000; (ii) interest expense of $1,963,000; and (iii) non-cash derivative expense of $69,807,000, which were partially offset by: (i) a gain from extinguishment of debt of $5,969,000 and (ii) other income of $107,000. This compared to a net loss of $6,961,000 for the same prior year period which included a loss from discontinued operations of $695,000. The Company had a net loss attributable to TLSS common shareholders of $67,655,000 for the three months ended June 30, 2020 as compared to a net loss attributable to TLSS common shareholders of $6,961,000 for the same prior year period.

Financial Results for the Six Months Ended June 30, 2020

Revenue for the six months ended June 30, 2020 increased $3,289,000, or 23.7%, to $17,194,000 as compared to $13,905,000 for same prior year period due to: Such increase was due primarily to: (i) the Company's expansion into new markets in Florida, Georgia, Ohio and Tennessee that were not operational during the first and second quarters of 2019; (ii) securing new business; (iii) a full six months of operations in its box-truck line of business that commenced in February 2019; and (iv) securing Payroll Protection Program loans which provided the funds needed to enable the Company to maintain its level of employed drivers to meet the increased delivery demand of its primary customer during the height of the COVID-19 pandemic.

The Company had a loss from operations of $2,748,000 for the six months ended June 30, 2020, which is comprised of (i) income from operating subsidiaries of $112,000 and (ii) a loss from the parent company of $2,860,000, of which $1,999,749 is attributable to non-cash stock-based compensation and consulting fees as compared to a loss from operations of $11,462,000 for the same prior year period.

The Company had a net loss of $71,109,000 for the six months ended June 30, 2020 due to: (i) the loss from operations of $2,748,000; (ii) interest expense of $5,117,000; and (iii) non-cash derivative expense of $69,662,000, which were partially offset by: (i) a gain from extinguishment of debt of $6,244,000 and (ii) other income of $175,000. This compared to a net loss of $26,609,000 for the same prior year period, which included a loss from discontinued operations of $681,000. The Company had a net loss attributable to TLSS common shareholders of $89,805,000 for the six months ended June 30, 2020 as compared to a net loss attributable to TLSS common shareholders of $26,609,000 for the same prior year period.

About Transportation and Logistics Systems, Inc.

TLSS operates as a leading logistics and transportation company specializing in eCommerce fulfillment, last mile, two-person home delivery and line haul services for predominantly online retailers through its wholly-owned operating subsidiaries, PrimeEFS, LLC and ShypDirect, LLC. For more information about the Company and its subsidiaries, visit the Company's website, www.tlss-inc.com.

Forward Looking Statements

Statements in this press release regarding the Company that are not historical facts are forward-looking statements and are subject to risks and uncertainties that could cause actual future events or results to differ materially from such statements. Any such forward-looking statements, including, but not limited to, financial guidance, are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements include all statements that do not directly or exclusively relate to historical facts. In some cases, you can identify forward-looking statements by terms such as "may," "will," "should," "could," "would," "expects," "plans," "anticipates," "intend," "plan," "goal," "seek," "strategy," "future," "likely," "believes," "estimates," "projects," "forecasts," "predicts," "potential," or the negative of those terms, and similar expressions and comparable terminology. These include, but are not limited to, statements relating to future events or our future financial and operating results, plans, objectives, expectations and intentions. Although we believe that the expectations reflected in these forward-looking statements are reasonable, these expectations may not be achieved. Forward-looking statements are neither historical facts nor assurances of future performance. Instead, they represent our intentions, plans, expectations, assumptions and beliefs about future events and are subject to known and unknown risks, uncertainties and other factors outside of our control that could cause our actual results, performance or achievement to differ materially from those expressed or implied by these forward-looking statements. In addition to the risks described above, these risks and uncertainties include: whether the OTC Markets Group approves our application to OTCQB; our ability to successfully execute our business strategies, including integration of acquisitions and the future acquisition of other businesses to grow our company; customers' cancellation on short notice of master service agreements from which we derive a significant portion of our revenue or our failure to renew such master service agreements on favorable terms or at all; our ability to attract and retain key personnel and skilled labor to meet the requirements of our labor-intensive business or labor difficulties which could have an effect on our ability to bid for and successfully complete contracts; the ultimate geographic spread, duration and severity of the coronavirus outbreak and the effectiveness of actions taken, or actions that may be taken, by governmental authorities to contain the outbreak or ameliorate its effects; our failure to compete effectively in our highly competitive industry could reduce the number of new contracts awarded to us or adversely affect our market share and harm our financial performance; our ability to adopt and master new technologies and adjust certain fixed costs and expenses to adapt to our industry's and customers' evolving demands; our history of losses, deficiency in working capital and a stockholders' deficit and our ability to achieve sustained profitability; material weaknesses in our internal control over financial reporting and our ability to maintain effective controls over financial reporting in the future; our substantial indebtedness could adversely affect our business, financial condition and results of operations and our ability to meet our payment obligations; the impact of new or changed laws, regulations or other industry standards that could adversely affect our ability to conduct our business; and changes in general market, economic and political conditions in the United States and global economies or financial markets, including those resulting from natural or man-made disasters.

These forward-looking statements represent our estimates and assumptions only as of the date of this release and, except as required by law, we undertake no obligation to update or revise publicly any forward-looking statements, whether as a result of new information, future events or otherwise after the date of this letter. Given these uncertainties, you should not place undue reliance on these forward-looking statements and should consider various factors, including the risks described, among other places, in our most recent Annual Report on Form 10-K and in our Quarterly Reports on Form 10-Q, as well as any amendments thereto, filed with the Securities and Exchange Commission.

Investor Relations:

Phone: 833.764.1443

Email: info@tlss-inc.com

TRANSPORTATION AND LOGISTICS SYSTEMS INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED BALANCE SHEETS

 

 
June 30,
 
 
December 31,
 

 

 
2020
 
 
2019
 

 

 
(Unaudited)
 
 
 
 

 

 
 
 
 
 
 

ASSETS

 
 
 
 
 
 

CURRENT ASSETS:

 
 
 
 
 
 

Cash

 

1,431,173
 
 

50,026
 

Accounts receivable, net

 
 
923,535
 
 
 
963,771
 

Prepaid expenses and other current assets

 
 
1,769,895
 
 
 
1,246,555
 

 

 
 
 
 
 
 
 
 

Total Current Assets

 
 
4,124,603
 
 
 
2,260,352
 

 

 
 
 
 
 
 
 
 

OTHER ASSETS:

 
 
 
 
 
 
 
 

Security deposit

 
 
207,250
 
 
 
76,500
 

Property and equipment, net

 
 
672,772
 
 
 
240,406
 

Right of use assets, net

 
 
1,621,290
 
 
 
1,750,430
 

 

 
 
 
 
 
 
 
 

Total Other Assets

 
 
2,501,312
 
 
 
2,067,336
 

 

 
 
 
 
 
 
 
 

TOTAL ASSETS

 

6,625,915
 
 

4,327,688
 

 

 
 
 
 
 
 
 
 

LIABILITIES AND SHAREHOLDERS' DEFICIT

 
 
 
 
 
 
 
 

 

 
 
 
 
 
 
 
 

CURRENT LIABILITIES:

 
 
 
 
 
 
 
 

Convertible notes payable, net of put premium of $0 and $385,385 and debt discounts of $2,275,670 and $2,210,950, respectively

 

4,126,079
 
 

3,634,344
 

Notes payable, current portion, net of debt discount of $0 and $762,112, respectively

 
 
4,252,538
 
 
 
2,425,003
 

Note payable – related party

 
 
500,000
 
 
 
500,000
 

Accounts payable

 
 
1,000,450
 
 
 
1,517,082
 

Accrued expenses

 
 
624,261
 
 
 
627,990
 

Insurance payable

 
 
3,201,872
 
 
 
2,948,261
 

Contingency liability

 
 
440,000
 
 
 
440,000
 

Lease liabilities, current portion

 
 
353,575
 
 
 
333,126
 

Derivative liability

 
 
62,813,098
 
 
 
2,135,939
 

Due to related parties

 
 
222,322
 
 
 
325,445
 

Accrued compensation and related benefits

 
 
1,233,565
 
 
 
886,664
 

 

 
 
 
 
 
 
 
 

Total Current Liabilities

 
 
78,767,760
 
 
 
15,773,854
 

 

 
 
 
 
 
 
 
 

LONG-TERM LIABILITIES:

 
 
 
 
 
 
 
 

Notes payable, net of current portion

 
 
510,766
 
 
 

 

Lease liabilities, net of current portion

 
 
1,300,180
 
 
 
1,440,258
 

 

 
 
 
 
 
 
 
 

Total Long-term Liabilities

 
 
1,810,946
 
 
 
1,440,258
 

 

 
 
 
 
 
 
 
 

Total Liabilities

 
 
80,578,706
 
 
 
17,214,112
 

 

 
 
 
 
 
 
 
 

Commitments and Contingencies (See Note 9)

 
 
 
 
 
 
 
 

 

 
 
 
 
 
 
 
 

SHAREHOLDERS' DEFICIT:

 
 
 
 
 
 
 
 

Preferred stock, par value $0.001; authorized 10,000,000 shares:

 
 
 
 
 
 
 
 

Series B convertible preferred stock, par value $0.001 per share; 1,700,000 shares designated; 1,700,000 shares issued and outstanding at June 30, 2020 and December 31, 2019, respectively (Liquidation value $1,700 and $1,700, respectively)

 
 
1,700
 
 
 
1,700
 

Series C preferred stock, par value $0.001 per share; 1 shares designated; No shares issued and outstanding at June 30, 2020 and December 31, 2019, respectively

 
 

 
 
 

 

Common stock, par value $0.001 per share; 4,000,000,000 shares authorized; 499,900,491 and 11,832,603 shares issued and outstanding at June 30, 2020 and December 31, 2019, respectively

 
 
499,900
 
 
 
11,833
 

Common stock issuable, par value $0.001 per share; 0 and 25,000 shares

 
 

 
 
 
25
 

Additional paid-in capital

 
 
75,966,151
 
 
 
47,715,878
 

Accumulated deficit

 
 
(150,420,542
)
 
 
(60,615,860
)

 

 
 
 
 
 
 
 
 

Total Shareholders' Deficit

 
 
(73,952,791
)
 
 
(12,886,424
)

 

 
 
 
 
 
 
 
 

Total Liabilities and Shareholders' Deficit

 

6,625,915
 
 

4,327,688
 

 
 
 
 
 
 
 
 
 

TRANSPORTATION AND LOGISTICS SYSTEMS INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(Unaudited)

 

 
For the Three Months Ended
 
 
For the Six Months Ended
 

 

 
June 30,
 
 
June 30,
 

 

 
2020
 
 
2019
 
 
2020
 
 
2019
 

 

 
 
 
 
 
 
 
 
 
 
 
 

REVENUES

 

8,558,815
 
 

8,101,412
 
 

17,193,875
 
 

13,904,619
 

 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

COST OF REVENUES

 
 
6,997,856
 
 
 
7,522,973
 
 
 
14,853,605
 
 
 
13,072,675
 

 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

GROSS PROFIT

 
 
1,560,959
 
 
 
578,439
 
 
 
2,340,270
 
 
 
831,944
 

 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

OPERATING EXPENSES:

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

Compensation and related benefits

 
 
662,503
 
 
 
3,608,670
 
 
 
1,404,548
 
 
 
7,717,214
 

Legal and professional fees

 
 
2,487,896
 
 
 
566,242
 
 
 
2,902,706
 
 
 
1,071,082
 

Rent

 
 
175,261
 
 
 
86,406
 
 
 
339,611
 
 
 
185,237
 

General and administrative expenses

 
 
196,368
 
 
 
930,203
 
 
 
441,651
 
 
 
1,595,535
 

Impairment loss

 
 

 
 
 
1,724,591
 
 
 

 
 
 
1,724,591
 

 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

Total Operating Expenses

 
 
3,522,028
 
 
 
6,916,112
 
 
 
5,088,516
 
 
 
12,293,659
 

 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

LOSS FROM OPERATIONS

 
 
(1,961,069
)
 
 
(6,337,673
)
 
 
(2,748,246
)
 
 
(11,461,715
)

 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

OTHER (EXPENSES) INCOME:

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

Interest expense

 
 
(1,940,912
)
 
 
(1,377,051
)
 
 
(4,987,639
)
 
 
(2,597,443
)

Interest expense – related parties

 
 
(22,438
)
 
 
(121,078
)
 
 
(129,576
)
 
 
(147,639
)

Loan fees

 
 
 
 
 
 
(601,121
)
 
 
 
 
 
 
(601,121
)

Gain on debt extinguishment, net

 
 
5,968,560
 
 
 
43,823,897
 
 
 
6,243,594
 
 
 
43,917,768
 

Other income

 
 
107,137
 
 
 

 
 
 
174,968
 
 
 

 

Derivative expense, net

 
 
(69,806,610
)
 
 
(41,653,345
)
 
 
(69,661,771
)
 
 
(55,037,605
)

 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

Total Other (Expenses) Income

 
 
(65,694,263
)
 
 
71,302
 
 
 
(68,360,424
)
 
 
(14,466,040
)

 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

LOSS FROM CONTINUING OPERATIONS

 
 
(67,655,332
)
 
 
(6,266,371
)
 
 
(71,108,670
)
 
 
(25,927,755
)

 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

LOSS FROM DISCONTINUED OPERATIONS:

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

Loss from discontinued operations

 
 

 
 
 
(695,087
)
 
 

 
 
 
(681,426
)

 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

NET LOSS

 
 
(67,655,332
)
 
 
(6,961,458
)
 
 
(71,108,670
)
 
 
(26,609,181
)

 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

Deemed dividend related to ratchet adjustment

 
 

 
 
 

 
 
 
(18,696,012
)
 
 

 

 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

NET LOSS ATTRIBUTABLE TO COMMON SHAREHOLDERS

 

(67,655,332
)
 

(6,961,458
)
 

(89,804,682
)
 

(26,609,181
)

 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

NET LOSS PER COMMON SHARE – BASIC AND DILUTED

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

Net loss from continuing operations

 

(0.26
)
 

(0.63
)
 

(0.66
)
 

(3.42
)

Loss from discontinued operations

 
 
(0.00
)
 
 
(0.07
)
 
 
(0.00
)
 
 
(0.09
)

 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

Net loss per common share – basic and diluted

 

(0.26
)
 

(0.70
)
 

(0.66
)
 

(3.51
)

 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

WEIGHTED AVERAGE COMMON SHARE OUTSTANDING:

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

Basic and diluted

 
 
261,417,292
 
 
 
9,891,525
 
 
 
136,885,211
 
 
 
7,573,522
 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

SOURCE: Transportation & Logistics Systems

ReleaseID: 601857

Aytu BioScience Announces Manufacture and Delivery of Healight(TM) Devices for Use in COVID-19 Clinical Study

Delivery of Investigational Endotracheal Ultraviolet-A Light Catheter Devices Enables Near-Term Initiation of Planned Clinical Studies in Severely Ill COVID-19 Patients

ENGLEWOOD, CO / ACCESSWIRE / August 17, 2020 / Aytu BioScience, Inc. (NASDAQ:AYTU), a specialty pharmaceutical company (the "Company") focused on commercializing novel products that address significant patient needs, today announced the delivery of Healight™ investigational devices. The delivery of these pilot scale Healight devices, designed and developed by Sterling Medical Devices ("Sterling"), enables the initiation of COVID-19 investigational clinical studies, which are expected to begin in the near-term.

Since Aytu signed a master services agreement with Sterling in April for Healight, the Company, Sterling, and its collaborators have sourced Healight device components and finalized design of the investigational devices for use in upcoming clinical studies.

Josh Disbrow, Chief Executive Officer of Aytu BioScience, commented, "A significant amount of work has gone into the development of the Healight investigational device, and we thank all of our collaborators for their efforts. We are looking forward to taking the next steps and advancing Healight as quickly as possible. As the COVID-19 pandemic continues, the investigation and development of novel potential therapies remains a high priority for numerous companies, and Aytu is proud to be part of this important effort. If Healight demonstrates safety and effectiveness in upcoming, planned studies, we are hopeful it can become an important tool in the COVID-19 fight."

The Healight technology platform employs proprietary methods of administering intermittent ultraviolet (UV) A light via a novel respiratory tract device. Pre-clinical findings indicate the technology's significant impact on reducing a wide range of viral and bacterial loads, including the coronavirus HCoV-229E. Recently published pre-clinical data have been the basis of discussions with the FDA for a path to enable human use for the potential treatment of SARS-CoV-2 in intubated patients in the intensive care unit (ICU). Beyond the initial pursuit of a potential SARS-CoV-2 ICU indication, additional experimental studies of mixed infection suggest broader potential clinical applications for the technology across a range of viral and bacterial pathogens. This may include nosocomial bacteria implicated in ventilator-associated pneumonia (VAP).

About Aytu BioScience, Inc.

Aytu BioScience is a commercial-stage specialty pharmaceutical company focused on commercializing novel products that address significant patient needs. The company currently markets a portfolio of prescription products addressing large primary care and pediatric markets. The primary care portfolio includes (i) Natesto®, the only FDA-approved nasal formulation of testosterone for men with hypogonadism (low testosterone, or "Low T"), (ii) ZolpiMist™, the only FDA-approved oral spray prescription sleep aid, and (iii) Tuzistra® XR, the only FDA-approved 12-hour codeine-based antitussive syrup. The pediatric portfolio includes (i) AcipHex® Sprinkle™, a granule formulation of rabeprazole sodium, a commonly prescribed proton pump inhibitor; (ii) Cefaclor, a second-generation cephalosporin antibiotic suspension; (iii) Karbinal® ER, an extended-release carbinoxamine (antihistamine) suspension indicated to treat numerous allergic conditions; and (iv) Poly-Vi-Flor® and Tri-Vi-Flor®, two complementary prescription fluoride-based supplement product lines containing combinations of fluoride and vitamins in various for infants and children with fluoride deficiency. Aytu also distributes a COVID-19 IgG/IgM rapid test. This coronavirus test is a solid phase immunochromatographic assay used in the rapid, qualitative and differential detection of IgG and IgM antibodies to the 2019 Novel Coronavirus in human whole blood, serum or plasma.

Aytu also operates a subsidiary focused on consumer health, Innovus Pharmaceuticals, Inc. ("Innovus"), a specialty pharmaceutical company commercializing, licensing and developing safe and effective consumer healthcare products designed to improve men's and women's health and vitality. Innovus commercializes over thirty-five consumer health products competing in large healthcare categories including diabetes, men's health, sexual wellness and respiratory health. The Innovus product portfolio is commercialized through direct-to-consumer marketing channels utilizing the company's proprietary Beyond Human® marketing and sales platform.

Aytu's strategy is to continue building its portfolio of revenue-generating Rx and consumer health products, leveraging its focused commercial team and expertise to build leading brands within large therapeutic markets. For more information visit aytubio.com and visit innovuspharma.com to learn about

About Sterling Medical Devices

Founded in 1998, Sterling Medical Devices (SMD), specializes in the product design and engineering of medical devices for the healthcare industry. Dedicated to resolving their clients' medical device design and engineering challenges, SMD addresses the whole development process, including, product design and human factors, systems, software, electronics, mechanical, quality, compliance, and global regulatory submissions. The company utilizes the latest tools and technology to streamline the engineering process to speed regulatory registrations, clearances, and/or approvals of Class I, II, and III devices. To date, the company has spearheaded the production of over 1,100 projects for more than 300 clients. SMD is internationally recognized and is FDA QSR 21 CFR Part 820 and Part 11 compliant, ISO 13485 registered, and IEC 62304, ISO 14971, IEC 60601, and IEC 62366 compliant. For more information, please visit www.sterlingmedicaldevices.com or call 201.227.7569 x2.

Forward-Looking Statement

This press release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, or the Exchange Act. All statements other than statements of historical facts contained in this presentation, are forward-looking statements. Forward-looking statements are generally written in the future tense and/or are preceded by words such as ''may,'' ''will,'' ''should,'' ''forecast,'' ''could,'' ''expect,'' ''suggest,'' ''believe,'' ''estimate,'' ''continue,'' ''anticipate,'' ''intend,'' ''plan,'' or similar words, or the negatives of such terms or other variations on such terms or comparable terminology. These statements are just predictions and are subject to risks and uncertainties that could cause the actual events or results to differ materially. These risks and uncertainties include, among others: market and other conditions, the regulatory and commercial risks associated with introducing the COVID-19 rapid test, the effectiveness of the COVID-19 rapid rest, market acceptance of the National Cancer Institute or other independently conducted studies' testing results, the regulatory, clinical, manufacturing, and commercial risks associated with the investigational Healight device, effects of the business combination of Aytu and the Commercial Portfolio and the merger ("Merger") with Innovus Pharmaceuticals, including the combined company's future financial condition, results of operations, strategy and plans, the ability of the combined company to realize anticipated synergies in the timeframe expected or at all, changes in capital markets and the ability of the combined company to finance operations in the manner expected, the diversion of management time on Merger-related issues and integration of the Commercial Portfolio, the ultimate timing, outcome and results of integrating the operations the Commercial Portfolio and Innovus with Aytu's existing operations, risks relating to gaining market acceptance of our products, obtaining or maintaining reimbursement by third-party payors for our prescription products, the potential future commercialization of our product candidates, the anticipated start dates, durations and completion dates, as well as the potential future results, of our ongoing and future clinical trials, the anticipated designs of our future clinical trials, anticipated future regulatory submissions and events, our anticipated future cash position and future events under our current and potential future collaboration. We also refer you to the risks described in ''Risk Factors'' in Part I, Item 1A of the company's Annual Report on Form 10-K and in the other reports and documents we file with the Securities and Exchange Commission from time to time.

Contact for Investors:

James Carbonara
Hayden IR
(646) 755-7412
james@haydenir.com

SOURCE: Aytu BioScience, Inc.

ReleaseID: 601817

Avidian Gold Completes Non-Brokered $1.7M Private Placement

NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES

TORONTO, ON / ACCESSWIRE / August 17, 2020 / Avidian Gold Corp. ("Avidian" or the "Company") (TSX-V:AVG) wishes to advise that it has closed its previously announced non-brokered private placement of units of the Company ("Units") at a price of $0.33 per Unit for gross proceeds of $1,700,000 (see press release dated August 4, 2020). Each Unit consists of one common share of the Company (a "Common Share") and one Common Share purchase warrant (a "Warrant") with each Warrant extensible into a Common Share at $0.55 per Common Share for twenty-four (24) months following the issuance of Warrants. The Company will have the right to accelerate the expiry of the Warrants to a date that shall be 30 days following the date of an acceleration notice given by the Company in the event that the VWAP of Common Shares shall equal or exceed $0.825 for 20 consecutive days following the expiration of the statutory hold period to which the Warrants will be subject.

The Offering was conducted in connection with the agreement between the Company and Crescat Capital LLC ("Crescat") pursuant to which Crescat, though its affiliates has acquired the entire offering of Units, and pursuant to which the Company has granted to Crescat a right to participate in future equity financings of the Company so as to maintain Crescat's pro-rata ownership of the securities of the Company, for as long as Crescat holds at least 5% in the Company's common Shares (on a partially-diluted basis).

The net proceeds from the Offering shall be primarily used for the development of Avidian's mineral properties and for general and administrative expenses.

The Units issued pursuant to the Offering are subject to a four month and a day statutory hold period in accordance with applicable Canadian securities laws. the Offering is subject to receipt of final approval of TSX Venture Exchange.

About Crescat Capital LLC

Crescat is a global macro asset management firm headquartered in Denver, Colorado, which deploys tactical investment themes based on proprietary value-driven equity and macro models. Crescat's investment goals are to provide industry leading absolute and risk-adjusted returns over complete business cycles with low correlation to common benchmarks and they apply their investment process across a mix of asset classes and strategies. Crescat is taking activist stakes in the precious metals exploration industry today as one of its key macro themes

About Avidian Gold Corp.

Avidian brings a disciplined and veteran team of project managers together with a regional scale advanced stage gold-copper exploration portfolio in Alaska. Avidian's Golden Zone project also hosts a NI 43-101 Indicated gold resource of 267,400 ounces (4,187,000 tonnes at 1.99 g/t Au) plus an Inferred gold resource of 35,900 ounces (1,353,000 tonnes at 0.83 g/t Au). Additional projects include the Amanita gold property which is adjacent to Kinross Gold's Fort Knox gold mine in Alaska and the Jungo gold/copper property in Nevada.

The information in respect of the Golden Zone project is adopted from the Technical Report on the Golden Zone Property, August 17, 2017, L. McGarry P.Geo & I. Trinder P.Geo, A.C.A Howe International Ltd (the "Technical Report").

Avidian is the majority owner of High Tide Resources, a private company with an option on the Labrador West iron ore property and owns the base metal Strickland Property and the Black Raven gold property, all located in Newfoundland and Labrador, Canada.

Avidian is focused on and committed to the development of advanced stage mineral projects throughout first world mining friendly jurisdictions using industry best practices combined with a strong social license from local communities. Further details on the Corporation and the individual projects, including the NI 43-101 Technical report on the Golden Zone property, can be found on the Corporation's website at www.avidiangold.com.

The technical information in this news release has been approved by Steve Roebuck, P.Geo and President of Avidian Gold, who is a Qualified Person as defined in National Instrument 43-101 – Standards of Disclosure for Mineral Projects.

For further information, please contact:

Steve Roebuck, President
E: sroebuck@avidiangold.com or +1(905) 741-5458
E: info@avidiangold.com

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this news release.

Forward-looking information

This News Release includes certain "forward-looking statements". These statements are based on information currently available to the Company and the Company provides no assurance that actual results will meet management's expectations. Forward-looking statements include estimates and statements that describe the Company's future plans, objectives or goals, including words to the effect that the Company or management expects a stated condition or result to occur. Forward-looking statements may be identified by such terms as "believes", "anticipates", "expects", "estimates", "may", "could", "would", "will", or "plan". Since forward-looking statements are based on assumptions and address future events and conditions, by their very nature they involve inherent risks and uncertainties. Although these statements are based on information currently available to the Company, the Company provides no assurance that actual results will meet management's expectations. Risks, uncertainties and other factors involved with forward-looking information could cause actual events, results, performance, prospects and opportunities to differ materially from those expressed or implied by such forward-looking information. Forward looking information in this news release includes, but is not limited to, the Company's objectives, goals or future plans, statements, exploration results, potential mineralization, the estimation of mineral resources, exploration and mine development plans, timing of the commencement of operations and estimates of market conditions. Factors that could cause actual results to differ materially from such forward-looking information include, but are not limited to: the ability to anticipate and counteract the effects of COVID-19 pandemic on the business of the Company, including without limitation the effects of COVID-19 on the capital markets, commodity prices supply chain disruptions, restrictions on labour and workplace attendance and local and international travel, failure to receive requisite approvals in respect of the Offering, failure to identify mineral resources, failure to convert estimated mineral resources to reserves, the inability to complete a feasibility study which recommends a production decision, the preliminary nature of metallurgical test results, delays in obtaining or failures to obtain required governmental, environmental or other project approvals, political risks, uncertainties relating to the availability and costs of financing needed in the future, changes in equity markets, inflation, changes in exchange rates, fluctuations in commodity prices, delays in the development of projects, capital and operating costs varying significantly from estimates and the other risks involved in the mineral exploration and development industry and those risks set out in the Company's public documents filed on SEDAR. Although the Company believes that the assumptions and factors used in preparing the forward-looking information in this news release are reasonable, undue reliance should not be placed on such information, which only applies as of the date of this news release, and no assurance can be given that such events will occur in the disclosed time frames or at all. These and other factors should be considered carefully and readers should not place undue reliance on the Company's forward-looking statements. The Company does not undertake to update any forward-looking statement that may be made from time to time by the Company or on its behalf, except in accordance with applicable securities law.

SOURCE: Avidian Gold Corp.

ReleaseID: 601943

Ocular Drug Delivery Technology Sales to Expand 1.4x through 2025, Demand to Drop During Covid-19 Owing to Delayed Elective Medical Procedures: Fact.MR

Ocular drug delivery technology manufacturers are largely investing in strategic industry collaborations, which will not only bolster portfolios, but will also help in consolidation during the crisis period.

ROCKVILLE, MD / ACCESSWIRE / August 17, 2020 / The global ocular drug delivery technology market is expected to grow 1.4x, with a 7.2% CAGR between 2020 and 2025. A new report by Fact.MR states that the coronavirus pandemic is likely to have adversely affected the ocular drug delivery technology market. Shortage of ocular drugs during the outbreak, coupled with the postponement of non-urgent ocular treatments during lockdown has reduced short term growth prospects for the market.

"Growing investments towards the research and development of novel drugs coupled with faster approvals from the FDA for pipeline drugs and ocular treatments, will play key roles in the development and growth of the ocular drug delivery technology industry," says the FACT.MR report.

Ocular Drug Delivery Technology Market- Key Takeaways

Ocular inserts are gaining major traction, owing to rapid onset of drug action and faster absorption upon administration.
Cataract and macular degeneration treatment applications account for significant revenues owing to rising cases of diabetes, and greater strain on eyes owing to urban work styles.
Asia Pacific is exhibiting high growth rate owing to low costs of drug delivery tech and the presence of regional manufacturers.

Request a sample of the report to gain in-depth market insights at

https://www.factmr.com/connectus/sample?flag=S&rep_id=4802

Ocular Drug Delivery Technology Market- Driving Factors

Strong demand and investments towards targeted ocular drug delivery techniques is a key contributor to market growth.
Improvements to reimbursement policies and rising government approvals boost growth prospects.

Ocular Drug Delivery Technology Market- Major Restraints

High capital investments required for the development of ocular dug delivery technologies hold back market expansion.
Discomfort associated with use of ocular drug delivery implants are hindering adoption rates.

COVID-19 Impact on Ocular Drug Delivery Technology Market

The worldwide pandemic of the coronavirus has had a substantial impact on ocular drug delivery systems. Demand has dropped sharply in the short term as healthcare resources are largely being redirected towards the covid-19 effort. Also, government guidelines to delay non-urgent medical procedures during lockdowns will hurt demand for ocular drug delivery technologies. Further, ophthalmic drug production has dropped during the pandemic. These factors will hurt market prospects in the short term. However, recovery is likely to be strong with the vast geriatric population and growing cases of ocular disorders.

Explore the global Ocular Drug Delivery Technology market with 94 figures, 42 data tables, along with the table of contents of the report. You can also find detailed segmentation on https://www.factmr.com/report/4802/ocular-drug-delivery-technology-market

Competitive Landscape

Santen Pharmaceutical Co. Ltd., Ocular Therapeutix Inc., Valeant Pharmaceuticals International, Alimera Sciences, and Allergan plc are some of the major players in the ocular drug delivery technology market.

Ocular drug delivery technology developers have been engaged in clinical trials and new product launches to increase geographic expansion and build on market collaborations.

For instance, Eyenovia Inc. has partnered with Arctic Vision for the development and commercialization of MicroLine ocular drug delivery systems. Glint Pharmaceuticals has initiated clinical trials for contact lens technology for the prevention of ocular covid-19 infections. Also, Eyepoint Pharmaceuticals Inc. has introduced DEXYCU drug delivery system for cataract treatments.

About the Report

This study offers readers a comprehensive market forecast of the ocular drug delivery technology market. Global, regional and country-level analysis of the top industry trends impacting the ocular drug delivery technology market is covered in this FACT.MR study. The report offers insights on the ocular drug delivery technology market on the basis of technology type (topical, ocular inserts, iontophoresis, in-situ gel and punctual plugs, and others), formulation (solution, suspension, emulsion, liposomes & nanoparticles, and ointment), disease (glaucoma, diabetic retinopathy, dry eye syndrome, macular degeneration, diabetic macular edema, cataract, and others) and end user (hospital, ambulatory surgical center, ophthalmic clinic, and home care) across five regions (North America, Latin America, Europe, Asia Pacific, and MEA).

Explore FACT.MR's Comprehensive Coverage of Healthcare Landscape

Drug Discovery Services Market– Get the latest insights on the global drug discovery services market through FACT.MR's report covering analysis for projection period (2017-2026).

MRI Guided Drug Delivery Market– FACT.MR's study on the MRI guided drug delivery market covers trends, tech innovations, players, and strategies for 2018-2028.

Drug Delivery Systems Market– Obtain analysis on the global drug delivery systems market through FACT.MR's latest report covering competitive analysis, regions, and segment analysis for 2020-2025.

About Fact.MR

Expert analysis, actionable insights, and strategic recommendations of the veteran research team at FACT.MR helps clients from across the globe with their unique business intelligence requirements. With a repository of over a thousand reports and 1 million+ data points, the team has scrutinized the healthcare sector across 50+ countries for over a decade. The team provides unmatched end-to-end research and consulting services.

Contact:

Fact.MR
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Email: sales@factmr.com
Web: https://www.factmr.com/
PR- https://www.factmr.com/media-release/1570/global-ocular-drug-delivery-technology-market

SOURCE: FactMR

ReleaseID: 601989

Polyol Sweeteners Market to Cross US$ 3.1 Bn by 2029; Industry to be Marginally Hurt by Raw Material Supply Disruptions During Covid-19 Outbreak – Future Market Insights

Polyol sweetener manufacturers are seeking to diversify regional raw material suppliers to mitigate potential disruptions in supplies, arising from trade and transport restrictions

DUBAI, UAE / ACCESSWIRE / August 17, 2020 / Despite the unprecedented impact of the coronavirus contagion around the globe, the polyol sweeteners market is unlikely to be severely affected for the duration of the crisis. Barring potential supply side disruptions, strong demand for processed and packaged foods during the pandemic will generate steady demand for polyol sweeteners in the short term. Robust distribution networks will shield the industry from the brunt of the outbreak.

"Polyol sweeteners are known for their low glycemic count, which makes its popular for consumption among diabetics. The global food and beverage industry, is generating strong demand for polyol sweetener as a low-calorie, sugar-free ingredient for healthy food products, which will boost consumption during the covid-19 pandemic," says the FMI report.

Download a Sample Report with Table of Contents and Figures: https://www.futuremarketinsights.com/reports/sample/rep-gb-11312

Polyol Sweeteners Market – Primary Takeaways

Sorbitol remains the most popular polyol sweetener variant, particularly among diabetics owing to a very low-calorie count.
Xylitol is gaining demand in high-intensity sweetener applications, driven by use in bakery and confectionery production settings.
Europe is a leading market for polyol sweeteners owing to strong government initiatives in the region to reduce sugar in diet.

Polyol Sweeteners Market – Growth Factors

Superior characteristics of mouthfeel, sweetness, and low-calorie value are key factors boosting the adoption of polyol sweeteners.
Growing cases of obesity and diabetics around the world will bolster the demand for foods and beverages incorporating polyol sweeteners.

Polyol Sweeteners Market – Major Constraints

Concerns over sweeteners sourced from bio-engineered materials are restricting adoption.
Strict regulations limiting the amount of polyol sweeteners in food products hurts application.

The Projected Impact of Coronavirus

The coronavirus pandemic has had a severe impact on the global economy and has resulted in transport and logistical restrictions arising from lockdown measures imposed by governments worldwide. These factors are likely to generate challenges for polyol sweetener producers as well. On the other hand, strong demand for healthy foods and beverages, and bias towards convenience foods will help in sustained demand for the duration of the pandemic. Strong distribution networks will help to mitigate losses in the industry.

We Offer tailor-made Solutions to fit Your Requirements, Request Customization@ https://www.futuremarketinsights.com/askus/rep-gb-11312

Competition Landscape

The polyol sweetener market comprises players including but not limited to HYET Sweet, Cargill Inc., Mitsubishi Corp., Archer Daniels Midland Co., Roquette Frères, Ingredion Inc., Zhejiang Huakang Pharmaceutical Co., Jungbunzlauer Suisse AG, and Gulshan Polyols Ltd.

Polyol sweetener market players have been pushing for research on new sources, product development and launches to expand their product portfolios and market presence.

For instance, Archer Daniels Midland Co. has acquired Florida Chemical Co. which will boost polyol sweetener production capacity. Mars Inc. has announced the development of a new chocolate formulation, replacing sugar with polyol sweetener to boost heat resistance. Further, Ingredion EMEA has launched its first polyol sweetener called Erysta Erythritol, aimed towards health-conscious consumers.

More About the Study

The FMI study provides detailed insights on polyol sweeteners. The market is broken down in terms of type (sorbitol, erythritol, maltitol, isomalt, and xylitol), form (powder and liquid), and application (bakery & confectionery, beverages, dairy, oral care, pharmaceuticals, and others) across seven key regions (North America, Latin America, Europe, South Asia, Oceania, East Asia, and Middle East, and Africa).

Buy Now@ https://www.futuremarketinsights.com/checkout/11312

Explore FMI's Coverage of the Food and Beverages Industry

Dietary Supplements Market: Find insights on the dietary supplements market with segment analysis, statistics, influencing factors, players and strategies adopted by market players for a 10-year forecast period.

Food Additives Market: FMI's report on the food additives market offers details on the market between 2016 -2026. The study covers influencers, revenue sources, market leaders, and strategies.

Nutritional Yeast Market: Get an in-depth analysis on the nutritional yeast market with insights on growth levers, opportunities, policies, restraints, regional markets and market leaders.

About Future Market Insights

Expert analysis, actionable insights, and strategic recommendations of the experienced research team at FMI helps clients from across the globe with their unique business intelligence requirements. With a repository of more than thousand reports and 1 million+ data points, the team has studied the food and beverages sector across 50+ countries for over a decade. The team provides unmatched end-to-end research and consulting services. Reach out to explore how we can help.

Contact

Mr. Abhishek Budholiya
Unit No: AU-01-H Gold Tower (AU), Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates

MARKET ACCESS DMCC Initiative
For Sales Enquiries: sales@futuremarketinsights.com
For Media Enquiries: press@futuremarketinsights.com
Report: https://www.futuremarketinsights.com/reports/polyol-sweeteners-market
Press Release Source: https://www.futuremarketinsights.com/press-release/polyol-sweeteners-market

SOURCE: Future Market Insights

ReleaseID: 601981